+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial



Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial



Neurology 85(23): 2084-2084




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057800563

Download citation: RISBibTeXText

PMID: 26644054

DOI: 10.1212/wnl.0000000000002206


Related references

Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial. Neurology 85(23): 2083-2084, 2015

Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD). Journal of Alzheimer's Disease 58(4): 1217-1228, 2017

Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial. Gastroenterology 121(5): 1088-1094, 2001

Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial. Biological Psychiatry 75(9): 678-685, 2014

A randomized, double-blind, placebo-controlled trial of subcutaneous etanercept in the treatment of moderate to severe Crohns disease. Gastroenterology 120(5 Suppl. 1): A 20, 2001

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85(16): 1383-1391, 2015

DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial. Neurology 62(6): 1030, 2004

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology 77(6): 556-563, 2011

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54(2): 295-301, 2000

Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent. Journal of Neural Transmission 109(7-8): 1089-1104, 2002

Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease. Geriatrics and Gerontology International 17(2): 211-218, 2017

Journal Club: a randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology 79(4): E33-E36, 2012

H2 histamine receptor blockade in the treatment of Alzheimer disease: a randomized, double-blind, placebo-controlled trial of nizatidine. Alzheimer Disease and Associated Disorders 16(1): 24-30, 2002

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. Journal of Clinical Psychopharmacology 28(1): 110-113, 2008

A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 31(2): 158-164, 2011